1
/32
/33
/3Medical Inquiries
Search our Medical Information database, try our temperature stability calculator, learn how to contact us, or report an adverse event
Therapeutic Areas
Find information on disease areas of interest, our products, and accredited continuing education programs
Explore Our Published Resources
Search our library of congress presentations and publications
Something went wrong, Please try again
Following Provell Pharmaceuticals' discontinuation of commercialization regarding Euthyrox® earlier in 2025, EMD Serono has made the difficult decision not to continue commercialization of Euthyrox® (Levothyroxine tablet) in the United States.
It is important to note that this discontinuation of product in the US is not related to the quality, safety, or efficacy of Euthyrox®. This decision was based on business considerations
Current Supply Status: Please note that the New Drug Application for Euthyrox® was withdrawn in November 2025 and it will become increasingly difficult to access remaining stock available in the US with expiration date of September 2026. We recommend proactive patient outreach and transition planning.
Support Available: We remain committed to supporting healthcare professionals and patients through this transition.
Contact Information:
Medical Information Team: 1-888-275-7376 (Mon-Fri, 8:00 AM- 5:30 PM ET)
Email: emediusa@emdserono.com
Website: medical.emdserono.com